Documents | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Documents

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Document Type

  • Publication (142)
  • Testimony (88)
  • Microgram (49)
  • DEA Administrator Remarks (29)
  • Speech (21)
  • In the News (5)
  • Announcements (3)

Publication Type

  • Intelligence (72)
  • DEA Administrator (39)
  • Forensics: Quality Management System Documents (32)
  • Drug Prevention (25)
  • Forensics (10)
  • Announcement (3)
  • Recruitment (1)

Drug Name

  • Narcóticos (opioides) (23)
  • Fentanyl (13)
  • Methamphetamine (10)
  • Drugs of Concern (7)
  • Heroin (7)
  • Cannabis (5)
  • Xylazine (5)
  • Marijuana (4)
  • Cocaine (2)
  • Synthetic Opioids (2)
  • Designer Drugs (1)
  • Hallucinogen (1)
  • Ketamine (1)
  • Spice/K2, Synthetic Marijuana (1)
  • Steroids (1)

Topic

  • Forensics: Quality Management System Documents (30)
  • Forensic Sciences (8)
  • Family (1)
  • Self Help/Personal Growth (1)
Clear All Results
340 Results - Showing 41 to 50
DOCUMENT
|
DEA Administrator Remarks

Administrator Milgram's Statement on Charges Filed in Connection with Matthew Perry's Fatal Overdose

Agosto 15, 2024
“Today we announce charges brought against the five individuals who, together, are responsible for the death of Matthew Perry. We allege each of the defendants played a key role in his death by falsely prescribing, selling, or injecting the ketamine that caused Matthew Perry’s tragic death. Matthew Perry’s journey began...
Agosto 15, 2024
DOCUMENT
|
DEA Administrator Remarks

Statement from Administrator Milgram on the Conviction of Haji Abdul Satar Abdul Manaf

Agosto 01, 2024
"Haji Abdul Satar Abdul Manaf was a double threat to the United States - he laundered money for terrorist organizations, like the Haqqani Network - which has kidnapped and held Americans, and he partnered with the Taliban to distribute heroin throughout the world. A DEA undercover agent met directly with...
Agosto 01, 2024
DOCUMENT
|
DEA Administrator Remarks

Statement from DEA Administrator Milgram on the Arrests of Ismael Zambada Garcia and Joaquin Guzman Lopez

Julio 25, 2024
“The arrest of Ismael Zambada García, better known as “El Mayo,” one of the alleged founders and leaders of the Sinaloa Cartel, strikes at the heart of the cartel that is responsible for the majority of drugs, including fentanyl and methamphetamine, killing Americans from coast to coast. El Mayo is...
Julio 25, 2024
DOCUMENT
|

State and Territory Report on Enduring and Emerging Threats (STREET) (May edition)

Julio 23, 2024
DEA has prepared this product primarily for law enforcement counterparts (state, local and tribal) and public safety and protection officials with a focus on enduring and emerging threats at both the national and regional levels. This report represents what will be the first of regular STREET reports prepared for and...
Julio 23, 2024
DOCUMENT
|
Speech

Principal Deputy Administrator Delivers Remarks on National Health Care Fraud Enforcement Action

Junio 27, 2024
In March 2020, in response to the COVID-19 pandemic, the federal government authorized the broader use of telemedicine services to allow patients access to needed health services and medications without requiring an in-person visit. While this ease of access to healthcare services expanded availability and convenience individuals like Ruthia He...
Junio 27, 2024
DOCUMENT
|
DEA Administrator Remarks

Administrator Milgram Announces Significant Development in International Drug Money Laundering Case

Junio 18, 2024
DEA is top operational priority is to defeat the cartels that are flooding the United States with deadly drugs like fentanyl and methamphetamine. The Sinaloa Cartel is a ruthless, violent, global criminal enterprise that is responsible for killing Americans and devastating communities from coast to coast. They do this for...
Junio 18, 2024
DOCUMENT
|
DEA Administrator Remarks

Statement from DEA Administrator Anne Milgram on Done Global Inc.

Junio 14, 2024
“The defendants in this case operated Done Global Inc., an online telehealth website that prescribed Adderall and other highly addictive medications to patients who bought a monthly subscription. The defendants allegedly preyed on Americans and put profits over patients by exploiting telemedicine rules that facilitated access to medications during the...
Junio 14, 2024
DOCUMENT
|
Publication

National Drug Threat Assessment 2024

Mayo 24, 2024
The 2024 National Drug Threat Assessment (NDTA) is a comprehensive strategic assessment of illicit drug threats endangering the United States. DEA’s goal in publishing the NDTA is to save American lives by raising awareness and understanding of these threats. This annual assessment provides law enforcement agencies, policy makers, and prevention...
Mayo 24, 2024
DOCUMENT
|
DEA Administrator Remarks

Administrator Anne Milgram Delivers Opening Statement Before the House Committee on Appropriations Commerce, Justice, Science Subcommittee

Mayo 07, 2024
"I want to thank the Subcommittee for inviting me to testify today on National Fentanyl Awareness Day. It is appropriate that on National Fentanyl Awareness Day, that I am given the opportunity to highlight for you the national tragedy that is being caused by fentanyl. According to the CDC, in...
Mayo 07, 2024
DOCUMENT
|
DEA Administrator Remarks

Statement from DEA Administrator Anne Milgram on the Increase in DEA Fentanyl Seizures Containing Xylazine

Abril 26, 2024
WASHINGTON – DEA first warned the public of a sharp increase in fentanyl seizures containing xylazine in our March 2023 Public Safety Alert . Since that time, xylazine’s growing prevalence in the fentanyl supply continues to make the deadliest drug threat facing this country even deadlier. In 2023, 30% of...
Abril 26, 2024

Paginación

  • Primera página «
  • Anterior
  • Página 4
  • Current page 5
  • Página 6
  • Página 7
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster